ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 92 filers reported holding ENDOCYTE INC in Q4 2013. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $20,000 | -4.8% | 14,200 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $21,000 | -41.7% | 14,200 | 0.0% | 0.01% | -53.8% |
| Q1 2017 | $36,000 | 0.0% | 14,200 | 0.0% | 0.01% | -27.8% |
| Q4 2016 | $36,000 | -18.2% | 14,200 | 0.0% | 0.02% | +50.0% |
| Q3 2016 | $44,000 | -4.3% | 14,200 | 0.0% | 0.01% | -29.4% |
| Q2 2016 | $46,000 | +4.5% | 14,200 | 0.0% | 0.02% | +21.4% |
| Q1 2016 | $44,000 | -22.8% | 14,200 | 0.0% | 0.01% | +16.7% |
| Q4 2015 | $57,000 | -12.3% | 14,200 | 0.0% | 0.01% | -67.6% |
| Q3 2015 | $65,000 | -12.2% | 14,200 | 0.0% | 0.04% | -5.1% |
| Q2 2015 | $74,000 | -16.9% | 14,200 | 0.0% | 0.04% | -39.1% |
| Q1 2015 | $89,000 | 0.0% | 14,200 | 0.0% | 0.06% | -5.9% |
| Q4 2014 | $89,000 | +3.5% | 14,200 | 0.0% | 0.07% | +6.2% |
| Q3 2014 | $86,000 | -8.5% | 14,200 | 0.0% | 0.06% | -9.9% |
| Q2 2014 | $94,000 | +118.6% | 14,200 | +256.3% | 0.07% | +61.4% |
| Q4 2013 | $43,000 | – | 3,985 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corbenic Partners LLC | 30,639 | $95,000 | 0.10% |
| Leisure Capital Management | 29,655 | $92,000 | 0.09% |
| Cribstone Capital Management, LLC | 32,541 | $101,000 | 0.08% |
| HIGHLAND CAPITAL MANAGEMENT LP | 442,656 | $1,372,000 | 0.06% |
| PINNACLE ASSOCIATES LTD | 898,096 | $2,784,000 | 0.06% |
| Bellevue Group AG | 100,000 | $310,000 | 0.06% |
| Baker Brothers Advisors | 1,695,865 | $5,257,000 | 0.06% |
| Curi RMB Capital, LLC | 217,885 | $675,000 | 0.04% |
| Spark Investment Management LLC | 116,300 | $360,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 244,192 | $757,000 | 0.02% |